Keyphrases
Overall Survival
100%
Pancreatic Cancer
75%
Metastatic Spinal Cord Compression
71%
Local Recurrence-free Survival
63%
Adjuvant Chemotherapy
56%
High-risk Stage II
53%
Hazard Ratio
51%
Disease-free Survival
51%
Oxaliplatin
50%
Non-inferiority
49%
Stage II Colorectal Cancer
47%
Short Course
47%
Platinum-based Chemotherapy
47%
Radiotherapy
43%
Pancreatic Ductal Adenocarcinoma
40%
YKL-40
37%
Chemotherapy
37%
Cost-effectiveness
35%
Motor Function
31%
Complete Blood Count
27%
Medicine and Dentistry
Colorectal Cancer
94%
Radiation Therapy
71%
Overall Survival
61%
Oxaliplatin
53%
Health Care Cost
50%
Adjuvant Chemotherapy
50%
Spinal Cord Compression
47%
Pancreas Cancer
47%
Oncology
47%
Randomized Controlled Trial
47%
Disease Free Survival
43%
Progression Free Survival
42%
Cost-Effectiveness Analysis
41%
Hazard Ratio
37%
Quality of Life
27%
Symptom
26%
Symptomatic Treatment
23%
Breast Cancer
23%
Collagen Type 3
23%
Restylane
23%
Nursing and Health Professions
Radiotherapy
47%
Spinal Cord Compression
47%
Overall Survival
41%
Progression Free Survival
40%
Palliative Therapy
23%
Oxaliplatin
23%
Adjuvant Chemotherapy
23%
Castration Resistant Prostate Cancer
23%
Apparent Diffusion Coefficient
23%
Group Therapy
23%
Colorectal Cancer
23%
Breast Cancer
23%
Nurse Specialist
23%
Patient-Reported Outcome
23%
Leukocyte Count
23%
Quality of Life
21%
Survival Rate
21%
Symptom
18%
Cost Effectiveness Analysis
17%
Neuropathy
17%
